Skip to main content

Table 1

From: High-dose chemotherapy with peripheral blood progenitor cell support in breast cancer: WSG AM01 and MM01

  AM 01 MM01
Patients Adjuvant N>9 M1, PR or CR after conventional
      induction, ER
Arm A Tandem-E,C,TT STAMP V
Arm B EC ×4 → CMF ×3 Tandem STAMP V
     q2w + G-CSF  
Actually randomized 368 180/480
Status Open Open
Treatment related 0% 1.5%
   mortality (%)